SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase

Epigenetics

Volumn 8, Issue 11, 2013, Pages 1162-1175

  Bueno, Murilo T D ^a,b   Richard, Stéphane ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Gene occupancy; HPC2; KDM5B; Lysine demethylase; Lysine methylation; RNF4; SUMOylation

Indexed keywords

HISTONE DEMETHYLASE; HISTONE H3; KDM5B; LYSINE; MESSENGER RNA; POLYCOMB GROUP PROTEIN; RING FINGER PROTEIN; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE PROGRESSION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE EXPRESSION; GENE OCCUPANCY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SUMOYLATION;

GENE OCCUPANCY; HPC2; KDM5B; LYSINE DEMETHYLASE; LYSINE METHYLATION; RNF4; SUMOYLATION;

ANIMALS; CELL LINE; HISTONES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LYSINE; METHYLATION; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION;

EID: 84887440904     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26112     Document Type: Article

References (64)

1. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, Whetstine JR, Bonni A, Roberts TM, Shi Y. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 2007; 128:1077-1088; PM I D:1732016 0; http://dx.doi.org/10.1016/j.cell.2007.02.017
2. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J, Hansen KH, Salcini AE, Helin K. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 2007; 128:1063-1076; PMID:17320161; http://dx.doi.org/10.1016/j.cell.2007.02.003
3. Lu PJ, Sundquist K, Baeckstrom D, Poulsom R, Hanby A, Meier-Ewert S, Jones T, Mitchell M, Pitha-Rowe P, Freemont P, et al. A novel gene (PLU-1) containing highly conserved putative DNA/ chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem 1999; 274:15 633-645; PMID:10336460; http://dx.doi.org/10.1074/jbc.274.22.15633
4. Xiang Y, Zhu Z, Han G, Ye X, Xu B, Peng Z, Ma Y, Yu Y, Lin H, Chen A P, et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA 2007; 104:19226-19231; PMID:18048344; http://dx.doi.org/10.1073/pnas.0700735104
5. Seward DJ, Cubberley G, Kim S, Schonewald M, Zhang L, Tr ipet B, Bentley DL. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat Struct Mol Biol 2007; 14:240-242; PMID:17310255; http://dx.doi.org/10.1038/nsmb1200
6. Xie L, Pelz C, Wang W, Bashar A, Varla mova O, Shadle S, Impey S. KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription. EMBO J 2011; 30:1473-1484; PMID:2144813 4; http://dx.doi.org/10.1038/emboj.2011.91
7. Schmitz SU, Albert M, Malatesta M, Morey L, Johansen JV, Bak M, Tommerup N, Abarrategui I, Helin K. Jarid1b targets genes regulating development and is involved in neural differentiation. EMBO J 2011; 30:4586-4600; PMID:22020125; http://dx.doi.org/10.1038/emboj.2011.383
8. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-Papadimitriou J, Tempst P, Zhang Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 2007; 25:801-812; PMID:17363312; http://dx.doi.org/10.1016/j.molcel.2007.03.001
9. Mitra D, Das PM, Huynh FC, Jones FE. Jumonji/ ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e. J Biol Chem 2011; 286:40531-40535; PMID:21969366; http://dx.doi.org/10.1074/jbc.M111.304865
10. Wong PP, Miranda F, Chan K V, Berlato C, Hurst HC, Scibetta AG. Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A). Mol Cell Biol 2012; 32:1633-1644; PMID:22371483; http://dx.doi.org/10.1128/MCB.06373-11
11. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141:583-594; PMID:20478252; http://dx.doi.org/10.1016/j.cell.2010.04.020
12. Dey BK, Stalker L, Schnerch A, Bhatia M, Taylor-Papidimitriou J, Wynder C. The histone demethylase KDM5b/JARID1b plays a role in cell fate decisions by blocking terminal differentiation. Mol Cell Biol 2008; 28:5312-5327; PMID:18591252; http://dx.doi.org/10.1128/MCB.00128-08
13. Chicas A, Kapoor A, Wang X, Aksoy O, Evertts AG, Zhang MQ, Garcia BA, Bernstein E, Lowe SW. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci USA 2012; 109:8971-8976; PM I D: 2 2 615 3 8 2; http://dx.doi.org/10.1073/pnas.1119836109
14. Nijwening JH, Geutjes EJ, Bernards R, Beijersbergen RL. The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS One 2011; 6:e25235; PMID:21980403; http://dx.doi.org/10.1371/journal.pone.0025235
15. Va n Rechem C, Black JC, Abbas T, Allen A, Rinehart CA, Yuan GC, Dutta A, Whetstine JR. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein. J Biol Chem 2011; 286:30462-30470; PMID:21757720; http://dx.doi.org/10.1074/jbc.M111.273508
16. Mallette FA, Mattiroli F, Cui G, Young LC, Hendzel MJ, Mer G, Sixma TK, Richard S. RNF8- and RNF168-dependent degradation of KDM4A/ JMJD2A triggers 53BP1 recruitment to DNA damage sites. The EMBO journal 2012; 31:1865-1878; PMID:22373579; http://dx.doi.org/10.1038/emboj.2012.47
17. Mersman DP, Du HN, Fingerman IM, South PF, Briggs SD. Polyubiquitination of the demethylase Jhd2 controls histone methylation and gene expression. Genes Dev 2009; 23:951-962; PMID:19346402; http://dx.doi.org/10.1101/gad.1769209
18. Baba A, Ohtake F, Okuno Y, Yokota K, Okada M, Imai Y, Ni M, Meyer CA, Igarashi K, Kanno J, et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 2011; 13:668-675; PMID:21532585; http://dx.doi.org/10.1038/ncb2228
19. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8:947-956; PMID:18000527; http://dx.doi.org/10.1038/nrm2293
20. Yeh ET. SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 2009; 284:8223-8227; PMID:19008217; http://dx.doi.org/10.1074/jbc.R800050200
21. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 2000; 275:13321-13329; PMID:10788439; http://dx.doi.org/10.1074/jbc.275.18.13321
22. Bies J, Markus J, Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J Biol Chem 2002; 277:8999-9009; PMI D:11779867; http://dx.doi.org/10.1074/jbc.M110453200
23. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998; 2:233-239; PMID:9734360; http://dx.doi.org/10.1016/S1097-2765(00)80133-1
24. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18:6455-6461; PMID:10562557; http://dx.doi.org/10.1093/emboj/18.22.6455
25. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18:6462-6471; PMID:10562558; http://dx.doi.org/10.1093/emboj/18.22.6462
26. Ross S, Best JL, Zon LI, Gill G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol Cell 2002; 10:831-842; PMID:12419227; http://dx.doi.org/10.1016/S1097-2765(02)00682-2
27. Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD. Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J Biol Chem 2001; 276:18513-18518; PMID:11278381; http://dx.doi.org/10.1074/jbc.M008066200
28. Hong Y, Rogers R, Matunis MJ, Mayhew CN, Goodson ML, Park-Sarge OK, Sarge KD. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem 2001; 276:40263-40267; P M I D: 1151455 7
29. Stindt MH, Carter S, Vigneron AM, Ryan KM, Vousden KH. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. Cell Cycle 2011; 10:3176-3188; PMID:2190 0752; http://dx.doi.org/10.4161/cc.10.18.17436
30. Lin X, Sun B, Liang M, Liang Y Y, Gast A, Hildebrand J, Brunicardi FC, Melchior F, Feng XH. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 2003; 11:1389-1396; PMID:12769861; http://dx.doi.org/10.1016/S1097-2765(03)00175-8
31. Girdwood D, Bumpass D, Vau g han OA, Thain A, Anderson LA, Snowden AW, Garcia-Wilson E, Perkins ND, Hay RT. P300 transcriptional repression is mediated by SUMO modification. Mol Cell 2003; 11:1043-1054; PMID:12718889; http://dx.doi.org/10.1016/S1097-2765(03)00141-2
32. Vethantham V, Rao N, Manley JL. Sumoylation regulates multiple aspects of mammalian poly(A) polymerase function. Genes Dev 2008; 22:499-511; PM I D: 182 814 63; http://dx.doi.org/10.1101/gad.1628208
33. Zhou W, Chen H, Zhang L. The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor. BMB Rep 2009; 42:154-159; PMID:19336002; http://dx.doi.org/10.5483/BMBRep.2009.42.3.154
34. MacPherson MJ, Beatty LG, Zhou W, Du M, Sadowski PD. The CTCF insulator protein is posttranslationally modified by SUMO. Mol Cell Biol 2009; 29:714-725; PM I D:19 029 252; http://dx.doi.org/10.1128/MCB.00825-08
35. Kagey MH, Melhuish TA, Wotton D. The polycomb protein Pc2 is a SUMO E3. Cell 2003; 113:127-137; PMID:12679040; http://dx.doi.org/10.1016/S0092-8674(03)00159-4
36. Long J, Zuo D, Park M. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J Biol Chem 2005; 280:35477-35489; PM I D: 16 0 6147 9; http://dx.doi.org/10.1074/jbc.M504477200
37. Li B, Zhou J, Liu P, Hu J, Jin H, Shimono Y, Takahashi M, Xu G. Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J 2007; 405:369-378; PMID:17439403; http://dx.doi.org/10.1042/BJ20061873
38. Roscic A, Möller A, Calzado MA, Renner F, Wimmer VC, Gresko E, Lüdi KS, Schmitz ML. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell 2006; 24:77-89; PMID:17018294; http://dx.doi.org/10.1016/j.molcel.2006.08.004
39. Oh Y, Chung KC. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling. J Biol Chem 2012; 287:17517-17529; PMID:22467880; http://dx.doi.org/10.1074/jbc.M111.336354
40. Ismail IH, Gagné JP, Caron MC, McDonald D, Xu Z, Masson JY, Poirier GG, Hendzel MJ. CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. Nucleic Acids Res 2012; 40:5497-5510; PMID:22402492; http://dx.doi.org/10.1093/nar/gks222
41. Pelisch F, Pozzi B, Risso G, Muñoz MJ, Srebrow A. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J Biol Chem 2012; 287:30789-30799; PMID:22825850; http://dx.doi.org/10.1074/jbc.M112.390120
42. Katoh H, Qin ZS, Liu R, Wa ng L, Li W, Li X, Wu L, Du Z, Lyons R, Liu CG, et al. FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1. Mol Cell 2011; 44:770-784; PM I D: 2 215 2 4 8 0; http://dx.doi.org/10.1016/j.molcel.2011.10.012
43. Li Q, Shi L, Gui B, Yu W, Wang J, Zhang D, Han X, Yao Z, Shang Y. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res 2011; 71:6899-6908; PM ID:2193768 4; http://dx.doi.org/10.1158/0008-5472.CAN-11-1523
44. Ren J, Gao X, Jin C, Zhu M, Wang X, Shaw A, Wen L, Yao X, Xue Y. Systematic study of protein sumoylation: Development of a site-specific predictor of SUMOsp 2.0. Proteomics 2009; 9:3409-3412; PMID:19504496; http://dx.doi.org/10.1002/pmic.200800646
45. Schneider CA, Rasband WS, Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9:671-675; PMID:22930834; http://dx.doi.org/10.1038/nmeth.2089
46. Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B, de Thé H. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 2008; 10:547-555; PMID:18408733; http://dx.doi.org/10.1038/ncb1717
47. Tatha m MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo JJ, Hay RT. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 2008; 10:538-546; PMID:18408734; http://dx.doi.org/10.1038/ncb1716
48. Weisshaar SR, Keusekotten K, Krause A, Horst C, Springer HM, Göttsche K, Dohmen RJ, Praefcke GJ. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. FEBS Lett 2008; 582:3174-3178; PMID:18708055; http://dx.doi.org/10.1016/j.febslet.2008.08.008
49. Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, Zhang XD, Bischof O, Seeler JS, Dejean A. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. EMBO J 2009; 28:3534-3548 PMID:19779455; http://dx.doi.org/10.1038/emboj.2009.279
50. van Hagen M, Overmeer RM, Abolvardi SS, Ver tegaal AC. RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha. Nucleic Acids Res 2010; 38:1922-1931; PMID:20026589; http://dx.doi.org/10.1093/nar/gkp1157
51. Luis NM, Morey L, Mejetta S, Pascual G, Janich P, Kuebler B, Cozutto L, Roma G, Nascimento E, Frye M, et al. Regulation of human epidermal stem cell proliferation and senescence requires polycomb-dependent and -independent functions of Cbx4. Cell Stem Cell 2011; 9:233-246; PMID: 21885019; http://dx.doi.org/10.1016/j.stem.2011.07.013
52. Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A, Necas E, Zavadil J, Laslo P, Stopka T. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J 2011; 30:4450-4464; PMID:21897363; http://dx.doi.org/10.1038/emboj.2011.317
53. Scibetta AG, Santangelo S, Coleman J, Hall D, Chaplin T, Copier J, Catchpole S, Burchell J, Taylor-Papadimitriou J. Functional analysis of the transcription repressor PLU-1/JARID1B. Mol Cell Biol 2007; 27:7220-7235; PM ID:17709396; http://dx.doi.org/10.1128/MCB.00274-07
54. Hao H, Kim DS, Klocke B, Johnson KR, Cui K, Gotoh N, Zang C, Gregorski J, Gieser L, Peng W, et al. Transcriptional regulation of rod photoreceptor homeostasis revealed by in vivo NRL targetome analysis. PLoS Genet 2012; 8:e1002649; PMID:22511886; http://dx.doi.org/10.1371/journal.pgen.1002649
55. Yang F, Hu L, Chen C, Yu J, O'Connell CB, Khodjakov A, Pagano M, Dai W. BubR1 is modified by sumoylation during mitotic progression. J Biol Chem 2012; 287:4875-4882; PMID:22167194; http://dx.doi.org/10.1074/jbc.M111.318261
56. Wang Y T, Yang WB, Chang WC, Hung JJ. Interplay of posttranslational modifications in Sp1 mediates Sp1 stability during cell cycle progression. J Mol Biol 2011; 414:1-14; PMID:21983342; http://dx.doi.org/10.1016/j.jmb.2011.09.027
57. Chung SS, Ahn BY, Kim M, Kho JH, Jung HS, Park KS. SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes. Biochem J 2011; 433:155-161; PMID:20950277; http://dx.doi.org/10.1042/BJ20100749
58. Smith M, Mallin DR, Simon JA, Courey AJ. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg. J Biol Chem 2011; 286:11391-11400; PMID:21278366; http://dx.doi.org/10.1074/jbc.M110.214569
59. Hu XV, Rodrigues TM, Tao H, Baker RK, Miraglia L, Orth A P, Lyons GE, Schultz PG, Wu X. Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screen. Proc Natl Acad Sci U S A 2010; 107:15087-15092; PMID:20696907; http://dx.doi.org/10.1073/pnas.1009025107
60. Krishnakumar R, Kraus WL. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 39:736-749; PMID:20832725; http://dx.doi.org/10.1016/j.molcel.2010.08.014
61. Kim J, Shin S, Subramaniam M, Bruinsma E, Kim TD, Hawse JR, Spelsberg TC, Janknecht R. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10. Biochem Biophys Res Commun 2010; 401:412-416; PMID:20863814; http://dx.doi.org/10.1016/j.bbrc.2010.09.068
62. Lee MG, Norman J, Shilatifard A, Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 2007; 128:877-887; PM I D:1732 0162; http://dx.doi.org/10.1016/j.cell.2007.02.004
63. Galisson F, Mahrouche L, Courcelles M, Bonneil E, Meloche S, Chelbi-Alix MK, Thibault P. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics 2011; 10:004796; PMID:21098080; http://dx.doi.org/10.1074/mcp.M110.004796
64. Pal S, Rosas JM, Rosas-Acosta G. Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs. J Virol Methods 2010; 163:498-504; PMID:19917317; http://dx.doi.org/10.1016/j.jviromet.2009.11.010